XanGo has been warned by the FDA for claiming that mangosteen could ward off disease or cancer. The company insists those claims were printed by a third party on a brochure at a recruitment seminar and it's not responsible.XanGo executives said they haven't heard from the FDA since receiving a warning letter last summer and assume the case is closed.
Paul Teitell, the FDA's assistant district director in Denver, said the matter isn't settled. The agency can seize the product, stop the company from doing business or prosecute, he said.
"The fact they haven't heard from us since last summer doesn't mean the case is closed," Teitell responded. "We warned them, and what happens beyond that warning is based on the way they behave, not how we behave."
